Asthma drug used in Japan may help fight progressive Muscular Dystrophy
CINCINNATI (WKRC) - New research is showing promise in the fight against multiple sclerosis.
A Japanese asthma drug may benefit those living with multiple sclerosis.
That is according to a study that was just presented at the European Committee for Treatment and Research in Multiple Sclerosis in Paris, France.
Researchers focused on people who have progressive multiple sclerosis, which is a degenerative form of the disease that attacks the brain and spinal cord.
This new drug, taken as a pill, is often used in japan to treat asthma and may slow the damage progressive MS causes in the brain.
Specialists at the Cleveland Clinic conducted the study. They found the drug called “Ibudilast” appears to help slowdown brain shrinking normally associated with this disease.
It actually cut it nearly in half to rates much closer to those seen in people who are healthy.
Researchers studied that in more than 250 people and compared it to a placebo.
Both groups had MRI brain scans and were followed for two years.
Results showed that the drug is safe and slows MS related brain shrinkage by 48 percent.